Paid hereditary haemorrahagic telangiectasia research studies
MediTalk runs paid healthcare research with patients and caregivers affected by hereditary haemorrahagic telangiectasia. If you're living with hereditary haemorrahagic telangiectasia, your perspective shapes the next generation of treatments, devices and patient services , and we pay for your time.
No open hereditary haemorrahagic telangiectasia studies right now
Register your interest below , we'll email you as soon as one opens.
Get on the list , it's two minutes.
We typically launch new hereditary haemorrahagic telangiectasia studies every few weeks. Registered participants hear about them before they go live on the public site.
Hereditary haemorrahagic telangiectasia research , frequently asked questions
Are MediTalk hereditary haemorrahagic telangiectasia studies paid?
Yes. Every MediTalk research study , including those focused on hereditary haemorrahagic telangiectasia , offers compensation for your time. Payment varies by study format and length, and is shown on each study's listing before you express interest.
Who can take part in hereditary haemorrahagic telangiectasia research on MediTalk?
Anyone diagnosed with hereditary haemorrahagic telangiectasia (and in some studies, family members or caregivers of someone with hereditary haemorrahagic telangiectasia) can register their interest. Each study has its own eligibility criteria (age, country, treatment history) shown on its listing , so you only spend time on studies you're actually a fit for.
How does a hereditary haemorrahagic telangiectasia study work in practice?
Most MediTalk hereditary haemorrahagic telangiectasia studies are remote and run on Zoom or a similar video platform , one-to-one interviews, focus groups or online surveys. Time commitment is shown on each listing (typically 30-90 minutes). You only need a quiet space, a webcam and a stable internet connection.
Is my hereditary haemorrahagic telangiectasia information kept private?
Yes. MediTalk is a UK-registered healthcare market-research platform run by Medicys Ltd, and all submissions are handled under UK GDPR. Your name and contact details are never shared with study sponsors , only de-identified research insights are reported back.
What if there are no open hereditary haemorrahagic telangiectasia studies right now?
Register your interest anyway , registration takes about two minutes, and you'll be the first to hear when a new hereditary haemorrahagic telangiectasia study opens. We typically launch new studies every few weeks across many conditions.
Ready to share your hereditary haemorrahagic telangiectasia experience?
Two minutes to register. We'll only contact you about studies that match what you've told us , no spam, no third-party sharing.